Unique substrate recognition by botulinum neurotoxins serotypes A and E

被引:76
作者
Chen, S [1 ]
Barbieri, JT [1 ]
机构
[1] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA
关键词
D O I
10.1074/jbc.M513032200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Botulinum neurotoxins (BoNTs) are zinc proteases that cleave SNARE proteins to elicit flaccid paralysis by inhibiting the fusion of neurotransmitter-carrying vesicles to the plasma membrane of peripheral neurons. There are seven serotypes of BoNT, termed A-G. BoNT serotype A and serotype E cleave SNAP25 at residues 197-198 and 180-181, respectively. Unlike other zinc proteases, the BoNTs recognize extended regions of SNAP25 for cleavage. The basis for this extended substrate recognition and specificity is unclear. Saturation mutagenesis and deletion mapping identified residues 156-202 of SNAP25 as the optimal cleavage domain for BoNT/A, whereas the optimal cleavage domain for BoNT/E was shorter, comprising residues 167-186 of SNAP25. Two sub-sites were resolved within each optimal cleavage domain, which included a recognition or active site (AS) domain that contained the site of cleavage and a binding (B) domain, which contributed to substrate affinity. Within the AS domains, the P1', P3, and P5 sites of SNAP25 contributed to scissile bond cleavage by LC/A, whereas the P1' and P2 sites of SNAP25 contributed to scissile bond cleavage by LC/E. These studies provide insight into the development of strategies for small molecule inhibitors of the BoNTs.
引用
收藏
页码:10906 / 10911
页数:6
相关论文
共 32 条
[1]   Structural analysis of botulinum neurotoxin serotype F light chain: Implications on substrate binding and inhibitor design [J].
Agarwal, R ;
Binz, T ;
Swaminathan, S .
BIOCHEMISTRY, 2005, 44 (35) :11758-11765
[2]   Analysis of active site residues of botulinum neurotoxin E by mutational, functional, and structural studies: Glu335Gln is an apoenzyme [J].
Agarwal, R ;
Binz, T ;
Swaminathan, S .
BIOCHEMISTRY, 2005, 44 (23) :8291-8302
[3]   The structure of the neurotoxin-associated protein HA33/A from Clostridium botulinum suggests a reoccurring β-trefoil fold in the progenitor toxin complex [J].
Arndt, JW ;
Gu, J ;
Jaroszewski, L ;
Schwarzenbacher, R ;
Hanson, MA ;
Lebeda, FJ ;
Stevens, RC .
JOURNAL OF MOLECULAR BIOLOGY, 2005, 346 (04) :1083-1093
[4]  
ARNON SS, 1978, LANCET, V1, P1273
[5]   The C-terminus of botulinum neurotoxin type A light chain contributes to solubility, catalysis, and stability [J].
Baldwin, MR ;
Bradshaw, M ;
Johnson, EA ;
Barbieri, JT .
PROTEIN EXPRESSION AND PURIFICATION, 2004, 37 (01) :187-195
[6]   New insights into clostridial neurotoxin-SNARE interactions [J].
Breidenbach, MA ;
Brunger, AT .
TRENDS IN MOLECULAR MEDICINE, 2005, 11 (08) :377-381
[7]   Substrate recognition strategy for botulinum neurotoxin serotype A [J].
Breidenbach, MA ;
Brunger, AT .
NATURE, 2004, 432 (7019) :925-929
[8]   Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells [J].
Dong, M ;
Richards, DA ;
Goodnough, MC ;
Tepp, WH ;
Johnson, EA ;
Chapman, ER .
JOURNAL OF CELL BIOLOGY, 2003, 162 (07) :1293-1303
[9]   Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: Correlation with its blockade of catecholamine release [J].
Foran, P ;
Lawrence, GW ;
Shone, CC ;
Foster, KA ;
Dolly, JO .
BIOCHEMISTRY, 1996, 35 (08) :2630-2636
[10]   RETRACTED: Cocrystal structure of synaptobrevin-II bound to botulinum neurotoxin type B at 2.0 Å resolution (Retracted article. See vol 16, pg 795, 2009) [J].
Hanson, MA ;
Stevens, RC .
NATURE STRUCTURAL BIOLOGY, 2000, 7 (08) :687-692